Jun 15, 2020 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Enhancing Drug Bioavailability and Solubility Approximately 40% of drugs on the market place and a high percentage of APIs in development are poorly soluble. Optimization of drug solubility and BA of therapeutics stands as one of the top challenges faced by the...
Jun 8, 2020 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Extended Duration Parenteral Products as Patient Adherence Strategies For a number of years, extended-release parenteral formulations have garnered enormous attention due to their effective drug concentrations over extended periods and improve patient compliance...
May 26, 2020 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Improving Adherence with Patient-Centric Formulations The term “patient centered,” “patient centric,” or “patient centricity” has increasingly grown in use in the scientific community in a wide variety of contexts. Generally, patient centric medicines are recognized...
Apr 15, 2020 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Controlled delivery formulations remain one of the favored tools for advancing the lifecycle of pharmaceutical products, and excipient selection is vitally important. A traditional strategy is to initially launch multiple daily doses of an immediate-release (IR)...
Apr 13, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Oral Peptide Therapeutics – Technologies have been honed to overcome many of the challenges of administering peptide therapeutics orally, but obstacles remain before drug developers can fully realize the vast potential. Numerous technologies are currently in...
Recent Comments